Sarepta Therapeutics (SRPT) EBITDA Margin Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,338.00 |
| Dec 31, 2025 | 74,867.00 |
| Sep 30, 2025 | 82,858.00 |
| Jun 30, 2025 | 61,423.00 |
| Mar 31, 2025 | -9,738.00 |
| Dec 31, 2024 | 26,002.00 |
| Sep 30, 2024 | 13,545.00 |
| Jun 30, 2024 | 29,359.00 |
| Mar 31, 2024 | 9,630.00 |
| Dec 31, 2023 | 17,722.00 |
| Sep 30, 2023 | 8,465.00 |
| Jun 30, 2023 | 3,777.00 |
| Mar 31, 2023 | -14,821.00 |
| Dec 31, 2022 | -2,112.00 |
| Sep 30, 2022 | -2,058.00 |
| Jun 30, 2022 | 6,939.00 |
| Mar 31, 2022 | -99,354.00 |
| Dec 31, 2019 | 16.44 Mn |
| Sep 30, 2019 | 263,420.00 |
| Jun 30, 2019 | 101,859.00 |
| Mar 31, 2019 | 37,743.00 |
| Dec 31, 2018 | 16,884.00 |
| Sep 30, 2018 | 91,153.00 |
| Jun 30, 2018 | 49,736.00 |
| Mar 31, 2018 | 88,549.00 |
| Dec 31, 2017 | 80,352.00 |
| Sep 30, 2017 | 55,045.00 |
| Jun 30, 2017 | -25,175.00 |
| Mar 31, 2017 | 67,286.00 |